Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.
|Articles|June 17, 2022
News Roundup: June 13 to June 17
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Next-In-Class Treatments Lead Oncology Drug Pipeline Update
The pipeline includes next-in-class treatments for melanoma, NSCLC, breast cancer, and multiple myeloma.
Hacking Diabetes: The DIY Bionic Pancreas Is Here to Stay
A do-it-yourself option to replace traditional diabetes management technology is growing in popularity.
Craving Connection, Pharmacists Celebrate a Return to In-Person Events
Transformation was top of mind at the 2022 American Associated Pharmacies (AAP) Annual Conference, where industry leaders, pharmacy owners, and AAP staff came together to celebrate their first annual meeting—live and in-person—since 2019.
FDA Approves Baricitinib Oral Tablets as First Systemic Alopecia Areata Treatment
The drug has previously been approved to treat moderately to severely active rheumatoid arthritis.
Integrated Health System Pharmacy Models Associated With Medication Adherence, Fewer Side Effects
Patient reported outcomes for were positive for those who filled medications at an integrated health system specialty pharmacy.
Advertisement
Related to this article
In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.
A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.
In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more.
Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.
In this episode, our hosts examine the expanding role of incretin therapies in children and adolescents with obesity and type 2 diabetes.
GLP-1 adherence requires integrated care teams, administrative technology, and proactive clinical support to tackle complex challenges.
Pharmacist Stephanie Young Moss explains menopause symptoms, hormone therapy guidance, and how pharmacists can expand menopause care access.
Advertisement
Advertisement
Trending on Drug Topics
1
FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms
2
FAQ: How the 2026 Midterms Could Reshape Pharmacy Policy
3
Addressing Medication Adherence in Cardiometabolic Health
4
How Pharmacists Can Join the Menopause Care Team
5